Stocks · Korea
092190
KOSDAQ
Seoul Viosys
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W-5.10%
1M+5.26%
3M+25.00%
6M+131.88%
1Y+196.85%
YTD+199.07%
52W high19,270원
52W low—
From 52W high-58.48%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 4,388억 | -621억 | -937억 | -14.2% |
| 2023 | 5,040억 | -729억 | -1,017억 | -14.5% |
| 2024 | 6,992억 | 35억 | 181억 | 0.5% |
| 2025 | 7,638억 | 2억 | -136억 | 0.0% |
| Quarterly | ||||
| 2024 4Q | 1,788억 | -40억 | -176억 | -2.2% |
| 2025 1Q | 1,678억 | -131억 | -173억 | -7.8% |
| 2025 2Q | 1,881억 | -9억 | -37억 | -0.5% |
| 2025 3Q | 1,875억 | -8억 | -41억 | -0.4% |
| 2025 4Q | 2,203억 | 151억 | 115억 | 6.8% |
| 2026 1Q | 1,878억 | 104억 | 103억 | 5.5% |
Company
Address: 경기도 안산시 단원구 산단로163번길 65-16 (원시동)
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Recent news
- 2026-05-11서울바이오시스, 1분기 영업익 108억…전년비 흑자전환 이데일리
- 2026-05-11서울바이오시스, 1분기 영업이익 108억원…“흑자전환” 전자신문
- 2026-04-15서울바이오시스, 1분기 잠정 매출 1887억 블로터
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.